Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Free University of Brussels
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Aug 11, 2023
Discovery & Translation
Bacteria to detect tumors; plus Netris’ mAb to block EMT in cancer and more
BioCentury’s roundup of translational innovations
BioCentury | Sep 21, 2022
Management Tracks
New CEOs at Scholar Rock, Neuway, NeuVasQ and ProLynx
Plus Serono’s Maria Rivas joins Pfizer, and updates from
BioCentury | Feb 18, 2022
Discovery & Translation
Engineered Wnt ligand restores BBB; plus Codiak, Autotac and more
BioCentury’s roundup of translational news
BioCentury | Jun 16, 2020
Finance
eTheRNA’s €34M series B to support different take on COVID-19 vaccine, build out core cancer pipeline
BioCentury | Apr 14, 2016
Distillery Therapeutics
Therapeutics: κ opioid receptor (KOR; OPRK1); µ opioid receptor (MOR; OPRM1); opioid receptor δ1 (OPRD1; DOR); prepronociceptin (PNOC; NOP)
Items per page:
1 - 10 of 23